Viatris to Buy Pacira BioSciences for $1.65 Billion

THE WALL STREET JOURNAL.

THURSDAY, OCTOBER 8, 2026

Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.

It's in today's paper. How big is it? Four answers, and your first pick has to be right to spot it.